Sharekhan

Healthcare Global Enterprises Ltd

Fri 30/05/2025,15:54:9 NSE: HCG

₹ 542.40 3.00 (0.56%)
BUY NOW Buy Healthcare Global Enterprises Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Healthcare Global Enterprises Ltd

Fri 30/05/2025,16:1:0

Healthcare Global Enterprises Ltd

Fri 30/05/2025,15:54:9 | NSE : HCG

₹ 542.403.00 (0.56%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 540.20

Previous Close

₹ 539.40

Volume

167870

Mkt Cap ( Rs. Cr)

₹7561.89

High

₹ 552.50

Low

₹ 540.00

52 Week High

₹ 639.00

52 Week Low

₹ 330.65

Book Value Per Share

₹ 61.82

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Healthcare Global Enterprises Ltd

Your Vote -

Buy

66.67%

Hold

25.00%

Sell

8.33%

66.67%

12 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

542.40

765

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

765

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Healthcare Global Enterprises Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    30 May 2025, 11:21PM Transcript of the Earnings Call held with Analysts/Investors on May 26, 2025.

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    30 May 2025, 11:21PM Healthcare Global Enterprises Limited has informed the Exchange about Transcript

  • Healthcare Global En - Amendment to AOA/MOA

    30 May 2025, 10:51PM Healthcare Global Enterprises Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.

  • Healthcare Global En - Appointment

    30 May 2025, 10:49PM Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Dr Manish Mattoo as Executive Director of the company w.e.f.

  • Healthcare Global En - Appointment

    30 May 2025, 10:46PM Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Dr Manish Mattoo as Chief Executive Officer of the company w

  • Healthcare Global En - Resignation

    30 May 2025, 10:37PM Healthcare Global Enterprises Limited has informed the Exchange regarding Resignation of Mr. Meghraj Arvindrao Gore as Chief Executive Officer of the

  • Healthcare Global En - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And

    30 May 2025, 10:34PM Execution of Supplementary Agreement on May 30, 2025 to the Promoter Agreement dated February 23, 2025 \r\n\r\nExecution of Supplementary Agreement o

  • Healthcare Global En - Amendment(s)

    30 May 2025, 10:34PM Healthcare Global Enterprises Limited has informed the Exchange about execution of supplementary agreement to the share purchase agreement between Ac

  • Healthcare Global En - Updates

    30 May 2025, 10:29PM Healthcare Global Enterprises Limited has informed the Exchange regarding 'We refer to our letter to the stock exchanges dated 23 February 2025 regard

  • Healthcare Global En - Intimation Under Regulation 31A(10) And Other Applicable Provisions Of SEBI (Listing Obligations And D

    30 May 2025, 10:28PM Reclassification of Aceso Company Pte Ltd from Promoter Category to Public Category effective from May 30, 2025 pursuant to the transfer of shares to

  • Healthcare Global En - Appointment

    30 May 2025, 10:21PM Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment and re-designation of Dr B S Ajaikumar as Non- Executive Directo

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Change in Directorate

    30 May 2025, 10:21PM Appointment and Redesignation of Dr. B.S. Ajaikumar as Non-Executive Director and Chairman of the Company with effect from May 30, 2025.\r\n\r\nAppoin

  • Healthcare Global En - Appointment

    30 May 2025, 10:07PM Healthcare Global Enterprises Limited has informed the Exchange regarding Appointment of Mr. Akshay Tanna as Non- Executive Director of the company w

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Change in Directorate

    30 May 2025, 10:07PM Appointment of Ms. Simrun Mehta and Mr. Akshay Tanna as Non-Executive and Non-Independent Directors of the Company with effect from May 30, 2025.

  • Healthcare Global En - Resignation

    30 May 2025, 9:58PM Healthcare Global Enterprises Limited has informed the Exchange regarding Resignation of Siddharth Tapaswin Patel as Non- Executive Director of the c

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Resignation of Director

    30 May 2025, 9:58PM Resignation of Mr. Siddharth Tapaswin Patel and Mr. Amit Soni as Non-Executive and Non- Independent Directors of the Company with effect from May 30,

  • Healthcare Global En - General Updates

    30 May 2025, 9:52PM Healthcare Global Enterprises Limited has informed the Exchange about change in promoter /promoter group of the company

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2025, 1:58PM Healthcare Global Enterprises Limited has informed the Exchange about Link of Recording

  • Healthcare Global En - Copy of Newspaper Publication

    26 May 2025, 1:38PM Healthcare Global Enterprises Limited has submitted to the Exchange copy of Newspaper Publication with respect to Audited Financial Results for the qu

  • Healthcare Global En - Earnings Call Held With Analysts/Investors To Discuss The Audited Financial Results Of The Quarter And

    26 May 2025, 1:59PM The Audio recording of Earnings Call held on May 26, 2025, with Analysts/Investors to discuss the Audited Financial Results for the quarter and year e

  • Healthcare Global En - Updates

    24 May 2025, 9:36PM Healthcare Global Enterprises Limited has informed the Exchange regarding 'Amendment to Insider Trading Policy and Code of Practices and Procedures fo

  • Healthcare Global En - Press Release

    24 May 2025, 8:45PM Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated May 24, 2025, titled ""Q4 & FY25 Financial & Business

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    24 May 2025, 8:45PM Press release on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2025.

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Investor Presentation

    24 May 2025, 8:39PM Investor Presentation on the financial results for the quarter and year ended March 31, 2025.

  • Healthcare Global En - Investor Presentation

    24 May 2025, 8:38PM Healthcare Global Enterprises Limited has informed the Exchange about Investor Presentation

  • Healthcare Global En - Integrated Filing (Financial)

    24 May 2025, 8:23PM The Board of Directors of the Company at its meeting held on May 24, 2025, has considered and approved the Audited Financial Results (Standalone and C

  • Healthcare Global En posts Q4 net profit of Rs 10.15 cr

    24 May 2025, 7:43PM The company reported standalone net profit during the quarter stood at Rs 10.15 crore compared to net loss of Rs 1.76 crore in the previous year quart

  • Healthcare Global En - Board Meeting Outcome for Annual Financial Results (Standalone And Consolidated) For Quarter And Year

    24 May 2025, 7:25PM The Board of Directors of the Company at its meeting held on May 24, 2025 has considered and approved the Audited Financial Results (Standalone and C

  • Healthcare Global En - Outcome of Board Meeting

    24 May 2025, 7:24PM Healthcare Global Enterprises Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    20 May 2025, 12:28PM Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    20 May 2025, 12:18PM Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    12 May 2025, 7:51PM Earings call of the Company scheduled on May 26, 2025 at 10.30 am to discuss the audited financials for the quarter and year ended March 31, 2025.

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    12 May 2025, 7:45PM Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet

  • Healthcare Global En - Board Meeting Intimation

    12 May 2025, 7:33PM Healthcare Global Enterprises Limited has informed the Exchange about Board Meeting to be held on 24-May-2025 to consider and approve the Quarterly Au

  • Healthcare Global En - Board Meeting Intimation for Considering, Approving And Taking On Record The Audited Financial Results

    12 May 2025, 7:26PM Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2025 ,inter alia, to

  • Healthcare Global En - General Updates

    8 May 2025, 4:51PM Healthcare Global Enterprises Limited has informed the Exchange that the Competition Authority of Kenya vide its letter dated 7 May 2025 has approved

  • Healthcare Global En - Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclo

    8 May 2025, 5:00PM HealthCare Global Enterprises Limited has informed the Exchange that the Competation Authority of Kenya vide its letter dated May 07, 2025 has approve

  • Healthcare Global En - Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclo

    2 May 2025, 5:02PM HCG has informed the stock exchanges that the Competition Commission of India vide its letter dated 1 May 2025, has approved the sale of upto 54% of v

  • Healthcare Global En - General Updates

    2 May 2025, 4:51PM Healthcare Global Enterprises Limited has informed the Exchange that the Competition Commission of India vide its letter dated 1 May 2025 has approved

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    28 Apr 2025, 6:29PM Scrutinizers report and voting results of the postal ballot for the agenda(s) listed in Postal Ballot Notice dated March 26, 2025, of HealthCare Globa

  • Healthcare Global En - Shareholders meeting

    28 Apr 2025, 6:23PM Healthcare Global Enterprises Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Ex

  • Healthcare Global En - Press Release

    21 Apr 2025, 4:37PM Healthcare Global Enterprises Limited has informed the Exchange regarding a press release dated April 21, 2025, titled ""Press release with respect to

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    21 Apr 2025, 4:54PM Press Release with respect to the inauguration of HCG Aastha Cancer Centre, Ahmedabad in the new premises.

  • Healthcare Global En - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    17 Apr 2025, 6:10PM Healthcare Global Enterprises Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Healthcare Global En - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Apr 2025, 6:09PM Certificate uner Reg 74(5) of SEBI (DP) Regulations.

  • Healthcare Global En - Spurt in Volume

    16 Apr 2025, 10:44AM Significant increase in volume has been observed in Healthcare Global Enterprises Limited. The Exchange, in order to ensure that investors have latest

  • Healthcare Global En - Announcement Under Regulation 30

    16 Apr 2025, 12:33PM Clarification on spurt in volume of security, accross exchanges

  • Healthcare Global En - Clarification sought from HealthCare Global Enterprises Ltd

    16 Apr 2025, 11:55AM The Exchange has sought clarification from HealthCare Global Enterprises Ltd on April 16, 2025, with reference to Movement in Volume. <BR><BR>The repl

  • Healthcare Global En - Spurt in Volume

    15 Apr 2025, 7:05PM Significant increase in volume has been observed in Healthcare Global Enterprises Limited. The Exchange, in order to ensure that investors have latest

  • Healthcare Global En has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 4:50PM As of March 2025, 71.22% is owned by Promoters and 28.78% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 10.87% and Fore

  • Healthcare Global En - Copy of Newspaper Publication

    29 Mar 2025, 11:30AM Healthcare Global Enterprises Limited has informed the Exchange about Copy of Newspaper Publication with respect to Postal Ballot Notice

  • Healthcare Global En - Trading Window-XBRL

    29 Mar 2025, 11:06AM HealthCare Global Enterprises Limited has informed the Exchange about Closure of Trading Window

  • Healthcare Global En - Trading Window

    29 Mar 2025, 11:03AM Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)

  • Healthcare Global En - Cautionary E-Mail From BSE Limited Dated March 28, 2025

    28 Mar 2025, 8:11PM Copy of cautionary e-mail received from BSE Limited with respect to the intimation of Schedule of Investors / Analysts' meet / Call held on February 2

  • Healthcare Global En - Action(s) taken or orders passed

    28 Mar 2025, 8:09PM Healthcare Global Enterprises Limited has informed the Exchange about Cautionary e-mail from National Stock Exchange of India Limited datedMarch 28, 2

  • Healthcare Global En - Notice Of Shareholders Meetings-XBRL

    28 Mar 2025, 5:33PM Healthcare Global Enterprises Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

  • Healthcare Global En - Shareholders meeting

    28 Mar 2025, 5:18PM Healthcare Global Enterprises Limited has informed the Exchange regarding Notice of Postal Ballot

  • Healthcare Global En - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    28 Mar 2025, 5:18PM Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Healthcare Global En - General Updates

    17 Mar 2025, 7:32PM Healthcare Global Enterprises Limited has informed the Exchange about General Updates on constitution of the committee of independent directors to pro

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    17 Mar 2025, 7:23PM Intimation under Regulation 30 and other applicable provisions of SEBI (LODR) Regulations, 2015 read with Regulaiton 26(6) of SEBI (SAST) Regulaitons,

  • Healthcare Global En - General Updates

    11 Mar 2025, 10:43AM Please find attached copy of the draft letter of offer received by the Company from Kotak MahindraCapital Company Limited in relation to the Open Offe

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Open Offer - Updates

    11 Mar 2025, 10:43AM Draft letter of offer received by the Company from Kotak Mahindra Capital Company Limited in relation to open offer for the acquisition of Equity Shar

  • Healthcare Global En - Draft Letter of Offer

    11 Mar 2025, 8:37AM Kotak Mahindra Capital Company Ltd. (\Manager to the Offer\) has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Health

  • Healthcare Global En - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Mar 2025, 11:53AM Healthcare Global Enterprises Limited has informed the Exchange about Transcript

  • Healthcare Global En - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 Mar 2025, 11:58AM Transcript of earnings call held with analysts/ investors on February 27, 2025

  • Healthcare Global En - Updates

    3 Mar 2025, 3:47PM Healthcare Global Enterprises Limited has informed the Exchange regarding 'Intimation under Regulation 30 and other applicable provisions of SEBI (Lis

  • Healthcare Global En - Announcement Under Regulation 30 Of SEBI (LODR) Regulations

    3 Mar 2025, 3:47PM Intimation under Regulation 30 and other applicable provisisons of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with

  • Healthcare Global En - Public Announcement-Open Offer

    3 Mar 2025, 3:20PM kotak mahindra Capital Company Ltd has submitted to the Exchange a copy of detailed public shatement in terms of Regulation 3(1), Regulation 4 Read w

  • Healthcare Global En - Detailed Public Statement

    3 Mar 2025, 2:33PM Kotak Mahindra Capital Company Ltd (\Manager to the Open Offer\) has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 3(1),

  • Healthcare Global Enterprises

    24 Feb 2025 , 9:03AM American private-equity giant KKR & Co will acquire up to a 54 per cent stake in hospital chain Healthcare Global Enterprises (HCG) from CVC Asia V for $400 million (approximately Rs 3,465 crore). KKR will purchase shares of HCG at Rs 445 apiece (11% discount to CMP) and make an open offer to the company’s shareholders to buy an additional 26 per cent. Negative

  • Healthcare Global to acquire majority stake in Vizag Hospital

    28 Jun 2024 , 1:54PM The company shall acquire a further 34% stake at Rs. 155 crore

  • Healthcare Global Enterprises

    27 Sep 2023 , 10:01AM According to media reports, Private equity firm CVC Capital Partners is considering selling a 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises. The stake is worth about $345 million (currently value at Rs2885crore). CVC may seek a premium of 20% for the shares or go as high as 50% depending on market conditions.

  • Healthcare Global Enterprises

    7 Jul 2023 , 11:22AM The Company entered into a Share Purchase Agreement with Dr Ajay Mehta, Dr Suchitra Mehta and shareholders of NCHRI, for the acquisition of entire equity share capital in Nagpur Cancer Hospital & Research Institute Pvt. Ltd (NCHRI). The completion of the acquisition is subject to the receipt of requisite approvals by NCHRI and other conditions. HCG currently holds 76% stake in the 115 beds Hospital. Post the acquisition it will be 100% subsidiary of the company. The cost of acquisition of entire shares (100%) in NCHRI would be INR 14.1 Crores, and the consideration payable to Dr.Ajay Mehta for the transfer of his partnership interest in HCG NCHRI LLP would be INR 17.6 Crores (which includes deferred consideration of INR 4.2 Crores). The turnover of NCHRL in FY2023 stood at ~Rs8crore with EBIDTA of Rs7.6crore.

  • Viewpoint: Healthcare Global Enterprises

    23 Mar 2023 , 2:06PM Viewpoint: Healthcare Global Enterprises – Improved growth visibility with favourable risk-reward

  • View Point: Healthcare Global Enterprises

    13 Dec 2022 , 11:09AM View Point: Healthcare Global Enterprises - Drivers in place to achieve consistent growth

  • Healthcare global enterprises

    2 Dec 2022 , 10:35AM Care rating has revised upwards the rating for the company to Care A+; Outlook – stable from Care A; outlook – stable. The revision in the rating assigned to the bank facilities of the company factors in the strong recovery in admissions and procedures performing translating into sustained improvement in its revenues and profitability – Positive read thru; preferred stock in the Hospital space.

  • Healthcare Global Enterprises

    20 Sep 2022 , 11:31AM BACC Health Care Private Limited (“Milann”), Wholly Owned Subsidiary of Healthcare Global Enterprises (HCG), is in discussions with Neonatal Care & Research Institute Private Limited (“Ovum”) with respect to a proposal for entering into a business combination arrangement, whereby HCG, post the completion of the Transaction, may hold a majority of the shareholding in the resultant entity. Ovum Hospitals, run by the Neonatal Care & Research Institute (NCRI), is an organization formed by a group of doctors with national and international experience in the field of pediatrics and gynaecology. It has around five centres in an around the city of Bangaluru.

  • Viewpoint: Healthcare Global

    27 Jun 2022 , 10:33AM Viewpoint: Healthcare Global - Bed capacity expansion and improved profitability to drive growth ahead

  • Healthcare Global Enterprises

    24 Jun 2022 , 10:34AM Healthcare Global Enterprises: The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur

  • Healthcare Global Enterprises

    24 Jun 2022 , 9:42AM The company Acquires radiant hospitals in Odisha, like to acquire majority stake in Cancer hospital in Nagpur and setting 25 bed capacity in Bangalore and expanding Ahmedabad hospital bed capacity (10-11% addition in the bed capacity 1720 over the next two years).

  • HCG acquires majority stake in Suchirayu HealthCare Solutions

    22 Nov 2021 , 10:02AM Acquisition of majority stake in Suchirayu Health care Solutions, Hubli, Karnataka.

  • Viewpoint: Healthcare Global - Q2FY22

    15 Nov 2021 , 2:13PM Viewpoint: Healthcare Global - Q2FY22 consolidated results review

  • HCG Q2FY022 consolidated

    12 Nov 2021 , 10:32AM Healthcare Global Enterprises: (HCG) Q2FY022 consolidated – strong operating performance

  • Healthcare Global Enterprises

    13 Oct 2021 , 9:56AM Healthcare Global Enterprises: Operations return to regular level post second wave; revenue stream at all time high

  • Healthcare Global Enterprises

    29 Sep 2021 , 12:16PM ICRA has upgraded long term – term loan/cash credit /overdraft to A+ (stable) from A- and on short term – non-fund based to A1 from A2+ - Positive read through for Healthcare Global Enterprises

  • Viewpoint: Healthcare Global Enterprises

    17 Sep 2021 , 9:58AM Viewpoint: Healthcare Global Enterprises - Unique business model to drive healthy cash flows

  • Healthcare Global Enterprises

    16 Sep 2021 , 10:50AM Rating agency care has upgraded rating of long term bank facilities of Rs489.2crore to Single A and Outlook stable – Positive read through for the stock.

  • HealthCare Global acquires oncology hospital labs from Strand Lifesciences

    6 Sep 2021 , 2:35PM HCG acquires oncology labs and divests stake in Strand Lifesciences to Reliance

  • Healthcare Global Enterprises

    6 Sep 2021 , 10:23AM The company acquires oncology labs & clinical trial business strand Lifesciences and simultaneously divested 38.5% stake in Strand to Reliance Industries HCG focusing on oncology, acquired oncology hospital labs and clinical trials business from Strand Lifesciences and simultaneous divestment of its ~38.5% stake (on paid-up capital basis and 34.5% on fully diluted basis) in Strand to Reliance Industries. HCG received consideration of ~INR 157cr for sale of its ownership in Strand and acquired labs and clinical research business through a Business Transfer Agreement (BTA) from Strand for a consideration of ~INR 81cr with a set-off of ~INR 7cr towards receivables. The transactions resulted in net cash inflow of ~INR 83cr for HCG in addition to the take-over of the labs and clinical research business. Strand will no longer continue to be an associate company of HCG post completion of this transaction

  • Healthcare Global board approves preferential allotment

    23 Nov 2017 , 11:17AM Healthcare Global announces that it will issue 11.66 lakh shares at Rs300 each on a preferential basis to Indgrowth Capital Fund 1

  • Healthcare Global to set up 12 hospitals in 18 months

    23 Aug 2017 , 9:18AM Healthcare Global Enterprises (HCG) plans to set up a dozen new hospitals over the next 18 months - positive read through for the stock.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Healthcare Global Enterprises Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1842.61 1584.073 1266.619 1205.14 1137.922
Liabilities 1842.61 1584.073 1266.619 1205.14 1137.922
Equity 139.42 139.29 139.116 139.012 125.359
Gross Profit 215.32 196.251 180.262 149 75.632
Net Profit 3.53 33.959 40.191 38.253 -191.547
Cash From Operating Activities 145.95 194.709 130.396 124.395 70.887
NPM(%) 0.27 3.08 3.99 4.48 -31.34
Revenue 1280.49 1099.29 1005.573 851.961 611.028
Expenses 1065.17 903.039 825.311 702.961 535.396
ROE(%) 0.4 3.94 4.66 4.43 -22.22

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Healthcare Global Enterprises Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.25 -0.44 26.62 309.56 301.39 0.62
Lotus Eye Hospital and Institute Ltd 71.90 -0.18 205.43 1127.99 3.55 0.00
Vaishali Pharma Ltd 12.69 -0.16 211.50 581.41 3.13 0.00
Astec Lifesciences Ltd 672.20 -0.91 0.00 1063.60 -687.10 0.00

Company Info

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

The Company was originally incorporated as Curie Centre of Oncology Private Limited on March 12, 1998 at Bengaluru, Karnataka, India as a private limited company under the Companies Act, 1956. The name of the Company was subsequently changed to HealthCare Global Enterprises Private Limited and a fresh certificate of incorporation consequent upon change of name was issued by the RoC on November 14, 2005. the Company was converted into a public limited company pursuant to a special resolution passed by the Shareholders at the EGM held on May 20, 2006 and the name of the Company was changed to HealthCare Global Enterprises Limited. A fresh certificate of incorporation consequent upon conversion to a public limited company was issued by the RoC on July 5, 2006. Major events and milestones of the Company : 2005 -Entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited 2006 -India Development Fund made its first investment of 500 million in the Company -BMORCL became the Subsidiary 2007 -HCG Medi-Surge became the Subsidiary -Evolvence made its first investment of 225 million in the Company 2008 -NTICPL made its first investment of 400 million in the Company 2009 -Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company 2010 -IL&FS Trust Company Limited a/c MPEF, through its scheme India Build Out Fund I and MAT made its first investment of 312 million in the Company 2011 -Amalgamation of BMORCL with the Company -PIOF became a Shareholder by purchasing shares from NTICPL 2013 -V-Sciences made its first investment of `600 million in the Company -Entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare 2014 -Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company 2015 -HCG Regency became the Subsidiary -Amalgamation of HCG Vijay with the Company -HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India in 2015 for its in-house research and development activities at HCG Towers, Bengaluru. -At Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards in 2015, Milann was recognised as the `Emerging IVF Service Provider Company of the Year'. 2016 -Company has entered into a Joint Venture Agreement on November 22, 2016, with HCG Regency Oncology Healthcare Pvt. Ltd -All India Critical Care Hospital Ranking Survey - 2016 -HCG Launches Advanced Comprehensive Cancer Centre in Baroda -Launch of HCG Vizag -HCG inaugurates TomoTherapy at its Centre of Excellence -HCG - The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2017 -HCG The Specialist in Cancer Care has been presented with the prestigious title of the `Best Medical Tourism Centre of Gujarat' during the Tourism Awards 2017 event. 2018 -Healthcare Global Enterprises Limited has approved the Scheme of Amalgamation of DKR with BACC on January 29, 2018 (?the Scheme?). BACC is a subsidiary of the Company, and DKR is a wholly owned subsidiary of BACC. -HCG Hospitals, Bhavnagar was recognised as the `Best Multispeciality Hospital' in Bhavnagar by Saurashtra Samachar in 2018. -HCG Cancer Centre, Ahmedabad was awarded as the `Best Cancer Hospital' by DivyaBhaskar in 2018. 2019 -Milann has been honoured with The National Icon Award 2018-19 for being `India's Most Trusted IVF Centre'. 2020 -During the 6th India Health and Wealth Awards in 2020, HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. -During the 6th India Health and Wealth Awards in 2020, HCG Hospitals, Ahmedabad was honoured with the `Silver Award' under the COVID Care Brand category. 2021 -Three centres from the HCG network, namely Bangalore, Mumbai and Vadodara bagged 1st, 3rd and 6th positions under the National Single Speciality - Oncology category in the Times Health's All India Critical Care Hospital Ranking Survey 2021. -Milann has been recognised as `The Best Fertility and IVF Chain in India' by ET Healthcare Brands. -HCG Cancer Centre, Ahmedabad, has been honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for `Excellence in Oncology' and `Excellence in Innovative Technology'. -HCG Cancer Centre, Ahmedabad, was ranked amongst the World's Best Hospitals 2021 by Newsweek Magazine. 2023 -HCG Cancer Hospital collaborates with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India -HealthCare Global Enterprises Limited becomes India's first mercury-free cancer care chain of hospitals. 2024 -The Company completed of acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited. -Healthcare Global Enterprises Ltd (HCG) partners with Trucan Diagnostics to Pioneer New Diagnostic Tests for Treatment Response Prediction and Monitoring in Cancer Patients. -HCG expands with two new state-of-the-art cancer care centres in Bengaluru. -HCG recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'

Read More

Parent Organisation

Healthcare Global Enterprises Ltd.

Founded

12/03/1998

Managing Director

Dr.B S Ajai Kumar

NSE Symbol

HCGEQ

FAQ

The current price of Healthcare Global Enterprises Ltd is ₹ 542.40.

The 52-week high for Healthcare Global Enterprises Ltd is ₹ 552.50 and the 52-week low is ₹ 540.00.

The market capitalization of Healthcare Global Enterprises Ltd is currently ₹ 7561.89. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Healthcare Global Enterprises Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Healthcare Global Enterprises Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Healthcare Global Enterprises Ltd shares.

The CEO of Healthcare Global Enterprises Ltd is Dr.B S Ajai Kumar, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT